Lifestyle intervention and anti-obesity therapies in the polycystic ovary syndrome: impact on metabolism and fertility

D Panidis, K Tziomalos, E Papadakis, C Vosnakis… - Endocrine, 2013 - Springer
Obesity is frequently present in patients with polycystic ovary syndrome (PCOS) and plays
an important role in the pathogenesis of the metabolic, endocrine, and reproductive …

The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome

D Panidis, K Tziomalos, E Papadakis… - Clinical …, 2014 - Wiley Online Library
Objective Obesity is frequently present in women with the polycystic ovary syndrome (PCOS)
and aggravates insulin resistance (IR) and hyperandrogenemia. We aimed to assess the …

Why does polycystic ovary syndrome (PCOS) need long-term management?

X Ruan, M Li, AO Mueck - Current pharmaceutical design, 2018 - ingentaconnect.com
Background: Polycystic ovary syndrome (PCOS) is a frequent female reproductive endocrine
disease. It has been associated with a number of severe reproductive and metabolic …

Polycystic ovary syndrome, obesity and reproductive implications

AL Hirschberg - Women's Health, 2009 - journals.sagepub.com
Polycystic ovary syndrome (PCOS) is one of the most common causes of female infertility,
affecting 5–10% of women of reproductive age. The syndrome is characterized by …

[HTML][HTML] Orlistat in polycystic ovarian syndrome reduces weight with improvement in lipid profile and pregnancy rates

P Kumar, S Arora - Journal of human reproductive sciences, 2014 - journals.lww.com
BACKGROUND: The effects of exercise, metformin, and orlistat on anthropometric
parameters, lipid profile, endocrine parameters, and ovulation in polycystic ovarian …

[HTML][HTML] Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels

D Panidis, D Farmakiotis, D Rousso, A Kourtis… - Fertility and sterility, 2008 - Elsevier
OBJECTIVE: To investigate the combined effect of diet and orlistat, for 24 weeks, on
anthropometric features, hormonal parameters, and indices of insulin resistance in obese …

Dietary therapy in polycystic ovary syndrome

LJ Moran, GD Brinkworth… - Seminars in reproductive …, 2008 - thieme-connect.com
Polycystic ovary syndrome (PCOS) is a common condition in women with reproductive age
associated with reproductive and metabolic dysfunction. Treatment has traditionally focused …

[HTML][HTML] Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society

LJ Moran, R Pasquali, HJ Teede, KM Hoeger… - Fertility and sterility, 2009 - Elsevier
OBJECTIVE: To summarize current evidence on lifestyle management (dietary, exercise, or
behavioral interventions) of obesity in women with polycystic ovary syndrome (PCOS), to …

Role of lifestyle modification in the management of polycystic ovary syndrome

KM Hoeger - Best practice & research Clinical endocrinology & …, 2006 - Elsevier
Overweight and obesity are common findings in polycystic ovary syndrome (PCOS). Obesity—
particularly central obesity—is strongly indicated as a cause of insulin resistance, a central …

Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies

TM Barber, P Hanson, MO Weickert… - Clinical Medicine …, 2019 - journals.sagepub.com
Polycystic ovary syndrome (PCOS) is a common female condition typified by reproductive,
hyperandrogenic, and metabolic features. Polycystic ovary syndrome is a genetic condition …